ADC Therapeutics SA Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q1 2023 to Q3 2024
-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
ADC Therapeutics SA quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2023 to Q3 2024.
- ADC Therapeutics SA Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 105M shares, a 27.4% increase year-over-year.
- ADC Therapeutics SA annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 81.7M shares, a 4.55% increase from 2022.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)